These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 10824099)

  • 1. Perlecan domain V of Drosophila melanogaster. Sequence, recombinant analysis and tissue expression.
    Friedrich MV; Schneider M; Timpl R; Baumgartner S
    Eur J Biochem; 2000 Jun; 267(11):3149-59. PubMed ID: 10824099
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The C-terminal domain V of perlecan promotes beta1 integrin-mediated cell adhesion, binds heparin, nidogen and fibulin-2 and can be modified by glycosaminoglycans.
    Brown JC; Sasaki T; Göhring W; Yamada Y; Timpl R
    Eur J Biochem; 1997 Nov; 250(1):39-46. PubMed ID: 9431988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structural basis of glycosaminoglycan modification and of heterotypic interactions of perlecan domain V.
    Friedrich MV; Göhring W; Mörgelin M; Brancaccio A; David G; Timpl R
    J Mol Biol; 1999 Nov; 294(1):259-70. PubMed ID: 10556044
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary structure of the human heparan sulfate proteoglycan from basement membrane (HSPG2/perlecan). A chimeric molecule with multiple domains homologous to the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.
    Murdoch AD; Dodge GR; Cohen I; Tuan RS; Iozzo RV
    J Biol Chem; 1992 Apr; 267(12):8544-57. PubMed ID: 1569102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Localization of glycosaminoglycan substitution sites on domain V of mouse perlecan.
    Tapanadechopone P; Hassell JR; Rigatti B; Couchman JR
    Biochem Biophys Res Commun; 1999 Nov; 265(3):680-90. PubMed ID: 10600481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The complete sequence of perlecan, a basement membrane heparan sulfate proteoglycan, reveals extensive similarity with laminin A chain, low density lipoprotein-receptor, and the neural cell adhesion molecule.
    Noonan DM; Fulle A; Valente P; Cai S; Horigan E; Sasaki M; Yamada Y; Hassell JR
    J Biol Chem; 1991 Dec; 266(34):22939-47. PubMed ID: 1744087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural properties of recombinant domain III-3 of perlecan containing a globular domain inserted into an epidermal-growth-factor-like motif.
    Schulze B; Mann K; Battistutta R; Wiedemann H; Timpl R
    Eur J Biochem; 1995 Aug; 231(3):551-6. PubMed ID: 7649154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perlecan, the large low-density proteoglycan of basement membranes: structure and variant forms.
    Noonan DM; Hassell JR
    Kidney Int; 1993 Jan; 43(1):53-60. PubMed ID: 8433569
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human basement membrane heparan sulfate proteoglycan core protein: a 467-kD protein containing multiple domains resembling elements of the low density lipoprotein receptor, laminin, neural cell adhesion molecules, and epidermal growth factor.
    Kallunki P; Tryggvason K
    J Cell Biol; 1992 Jan; 116(2):559-71. PubMed ID: 1730768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural characterization of recombinant domain II of the basement membrane proteoglycan perlecan.
    Costell M; Sasaki T; Mann K; Yamada Y; Timpl R
    FEBS Lett; 1996 Nov; 396(2-3):127-31. PubMed ID: 8914972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of human perlecan domain I as a recombinant heparan sulfate proteoglycan with 20-kDa glycosaminoglycan chains.
    Graham LD; Whitelock JM; Underwood PA
    Biochem Biophys Res Commun; 1999 Mar; 256(3):542-8. PubMed ID: 10080934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Products of the unc-52 gene in Caenorhabditis elegans are homologous to the core protein of the mammalian basement membrane heparan sulfate proteoglycan.
    Rogalski TM; Williams BD; Mullen GP; Moerman DG
    Genes Dev; 1993 Aug; 7(8):1471-84. PubMed ID: 8393416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structural and cell-adhesive properties of three recombinant fragments derived from perlecan domain III.
    Schulze B; Sasaki T; Costell M; Mann K; Timpl R
    Matrix Biol; 1996 Nov; 15(5):349-57. PubMed ID: 8981331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant domain IV of perlecan binds to nidogens, laminin-nidogen complex, fibronectin, fibulin-2 and heparin.
    Hopf M; Göhring W; Kohfeldt E; Yamada Y; Timpl R
    Eur J Biochem; 1999 Feb; 259(3):917-25. PubMed ID: 10092882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drosophila laminin binds to mammalian nidogen and to heparan sulfate proteoglycan.
    Mayer U; Mann K; Fessler LI; Fessler JH; Timpl R
    Eur J Biochem; 1997 May; 245(3):745-50. PubMed ID: 9183014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Binding of the G domains of laminin alpha1 and alpha2 chains and perlecan to heparin, sulfatides, alpha-dystroglycan and several extracellular matrix proteins.
    Talts JF; Andac Z; Göhring W; Brancaccio A; Timpl R
    EMBO J; 1999 Feb; 18(4):863-70. PubMed ID: 10022829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelial cells interact with the core protein of basement membrane perlecan through beta 1 and beta 3 integrins: an adhesion modulated by glycosaminoglycan.
    Hayashi K; Madri JA; Yurchenco PD
    J Cell Biol; 1992 Nov; 119(4):945-59. PubMed ID: 1385448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Widespread expression of perlecan proteoglycan in basement membranes and extracellular matrices of human tissues as detected by a novel monoclonal antibody against domain III and by in situ hybridization.
    Murdoch AD; Liu B; Schwarting R; Tuan RS; Iozzo RV
    J Histochem Cytochem; 1994 Feb; 42(2):239-49. PubMed ID: 7507142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody mapping and tissue localization of globular and cysteine-rich regions of perlecan domain III.
    Couchman JR; Ljubimov AV; Sthanam M; Horchar T; Hassell JR
    J Histochem Cytochem; 1995 Sep; 43(9):955-63. PubMed ID: 7543915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of recombinant perlecan domain I and its substitution by glycosaminoglycans and oligosaccharides.
    Costell M; Mann K; Yamada Y; Timpl R
    Eur J Biochem; 1997 Jan; 243(1-2):115-21. PubMed ID: 9030729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.